von Figura K, Kresse H
J Clin Invest. 1974 Jan;53(1):85-90. doi: 10.1172/JCI107563.
The cellular uptake of N-acetyl-alpha-D-glucosaminidase, the deficient enzyme in Sanfilippo B disease, and the intracellular fate and metabolic effect of this enzyme have been investigated in Sanfilippo B and normal fibroblasts. For both genotypes the uptake is highly efficient (up to 0.025 mU/h/mg cell protein), specific and constant over a period of at least 6 days. It is probable that the enzyme protein is taken up by adsorptive pinocytosis. The enzymatic activity as well as the biological activity towards (35)SO(4)-labeled mucopolysaccharides persist in Sanfilippo B cells with a half-life of 34 h, indicating the intralysosomal localization of the pinocytosed enzyme. The data obtained are discussed with regard to a possible enzyme replacement therapy. For Sanfilippo B disease the doses used in the past are considered to be insufficient to cause measurable effects.
在桑菲利波B病和正常成纤维细胞中,对N-乙酰-α-D-氨基葡萄糖苷酶(桑菲利波B病中的缺陷酶)的细胞摄取、该酶的细胞内命运和代谢作用进行了研究。对于这两种基因型,摄取效率都很高(高达0.025 mU/小时/毫克细胞蛋白),在至少6天的时间内具有特异性且保持恒定。酶蛋白很可能是通过吸附性胞饮作用被摄取的。酶活性以及对(35)SO(4)标记的粘多糖的生物活性在桑菲利波B细胞中持续存在,半衰期为34小时,表明胞饮摄入的酶定位于溶酶体内。就可能的酶替代疗法对所获得的数据进行了讨论。对于桑菲利波B病,过去使用的剂量被认为不足以产生可测量的效果。